DOES TESTING FOR CIRCULATING AUTOANTIBODIES AGAINST DISEASE-RELEVANT CITRULLINATED ANTIGENS ADD VALUE TO THE CCP2 ASSAY IN DIAGNOSING RA AMONG EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS?

Samankaltaisia teoksia

• DOES TESTING FOR CIRCULATING AUTOANTIBODIES AGAINST DISEASE-RELEVANT CITRULLINATED ANTIGENS ADD VALUE TO THE CCP2 ASSAY IN DIAGNOSING RA AMONG EARLY UNDIFFERENTIATED ARTHRITIS PATIENTS?
  Tekijä: Pratt, A, et al.
  Julkaistu: (2011)
• Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort.
  Tekijä: Pratt, A, et al.
  Julkaistu: (2011)
• Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort
  Tekijä: Pratt, A, et al.
  Julkaistu: (2011)
• A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis
  Tekijä: Heather A. Nelson, et al.
  Julkaistu: (2024-08-01)
• Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis Reply
  Tekijä: Lundberg, K, et al.
  Julkaistu: (2010)